Study ID: MS-LAQ-302 | EUDRACT 2007-005450-23
Study Title
- BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon ־²-1a (Avonexֲ®)
Teva Identifier
- MS-LAQ-302 | EUDRACT 2007-005450-23
ClinicalTrials.gov Identifier
- NCT00605215
Study Status
- Completed
Trial Condition(s)
- Multiple Sclerosis
Interventions
- Drug: laquinimod | Drug: placebo | Drug: Interferon ־²-1a (Avonexֲ®)
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 55 Years
Trial Duration
- 04/01/2008 - 12/01/2011
Phase
- Phase 3
Study Type
Interventional
